Cargando…

Unmasking metabolic dependencies in pancreatic cancer: aberrant polyamine synthesis as a promising new therapeutic target

Detalles Bibliográficos
Autores principales:	Wolters-Eisfeld, Gerrit, Hackert, Thilo, Güngör, Cenap
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Research Highlight
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10603029/ https://www.ncbi.nlm.nih.gov/pubmed/37884518 http://dx.doi.org/10.1038/s41392-023-01662-7

Ejemplares similares

Highlight: The Evolutionary Fates of Supergenes Unmasked
por: McGrath, Casey
Publicado: (2021)

COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer
por: Hofmann, Bianca T., et al.
Publicado: (2015)

In search for novel strategies towards neuroprotection and neuroregeneration: is PPARα a promising therapeutic target?
por: Moreno, Sandra, et al.
Publicado: (2015)

Unmasking a role for sex chromosomes in gene silencing
por: Maatouk, Danielle M, et al.
Publicado: (2010)

Polyamine Metabolism in Leishmania Parasites: A Promising Therapeutic Target
por: Carter, Nicola S., et al.
Publicado: (2022)

Targeting menin: a promising therapeutic strategy for susceptible acute leukemia subtypes
por: Di Fazio, Pietro
Publicado: (2023)

Targeting chemokines/chemokine receptors: a promising strategy for enhancing the immunotherapy of pancreatic ductal adenocarcinoma
por: Gong, Ruining, et al.
Publicado: (2020)

Targeting the entry step of SARS-CoV-2: a promising therapeutic approach
por: Li, Jing, et al.
Publicado: (2020)

Constrained surfaces: promising therapeutic targets for COVID-19 determined by systematically mutational analysis
por: Wang, Manni, et al.
Publicado: (2021)

A novel mechanism of ferroptosis surveillance offers promising therapeutic avenues for breast and prostate cancers
por: Xu, Rongyang, et al.
Publicado: (2023)

Loss of complex O-glycosylation impairs exocrine pancreatic function and induces MODY8-like diabetes in mice
por: Wolters-Eisfeld, Gerrit, et al.
Publicado: (2018)

Towards the Ideal Synthesis of Homoallylic Ketones
por: Ferrer, Sofía, et al.
Publicado: (2015)

Machine Learning for Organic Synthesis: Are Robots Replacing Chemists?
por: Maryasin, Boris, et al.
Publicado: (2018)

Promising biotechnological applications of antibiofilm exopolysaccharides
por: Bernal, Patricia, et al.
Publicado: (2012)

Innate immune signaling and immunothrombosis: New insights and therapeutic opportunities
por: Ryan, Tristram A. J., et al.
Publicado: (2022)

Regulatory T cells as a therapeutic approach for inflammatory bowel disease
por: Laukova, Marcela, et al.
Publicado: (2023)

mRNA vaccine shows promise in autoimmunity
por: Flemming, Alexandra
Publicado: (2021)

Prostaglandin regulation of type 2 inflammation: From basic biology to therapeutic interventions
por: Oyesola, Oyebola O., et al.
Publicado: (2021)

Memory of Chirality as a Prominent Pathway for the Synthesis of Natural Products through Chiral Intermediates
por: Hardwick, Tomas, et al.
Publicado: (2018)

A promising vaccine candidate against COVID-19
por: Wang, Xiwei, et al.
Publicado: (2020)

Dietary intervention, a promising adjunct for cancer therapy
por: Shi, Rongchen, et al.
Publicado: (2020)

Practical Synthesis of Polyamine Succinamides and Branched Polyamines
por: Alkhzem, Abdulaziz H., et al.
Publicado: (2022)

Janus kinase signaling as risk factor and therapeutic target for severe SARS‐CoV‐2 infection
por: Solimani, Farzan, et al.
Publicado: (2021)

Targeting B cells and plasma cells in autoimmune diseases: From established treatments to novel therapeutic approaches
por: Merino‐Vico, Ana, et al.
Publicado: (2022)

Pannexin-1-dependent caspase-1 activation and secretion of IL-1β is regulated by zinc
por: Brough, David, et al.
Publicado: (2009)

Proteomics promises a new era of precision cancer medicine
por: Wu, Chong, et al.
Publicado: (2019)

Surrogate cytokine agonists: promising agents against COVID-19
por: Lin, Zemin, et al.
Publicado: (2022)

Bispecific immune molecule PD1-IL2v: a new therapeutic strategy for pancreatic ductal adenocarcinoma
por: Gao, Yuan, et al.
Publicado: (2023)

Targeting mRNA translation aberrations: A novel approach for therapy in chronic lymphocytic leukemia
por: Klapp, Vanessa, et al.
Publicado: (2023)

Antigen‐dependent multistep differentiation of T follicular helper cells and its role in SARS‐CoV‐2 infection and vaccination
por: Baumjohann, Dirk, et al.
Publicado: (2021)

Hydrogen sulfide controls peripheral nerve degeneration and regeneration: a novel therapeutic strategy for peripheral demyelinating disorders or nerve degenerative diseases
por: Jung, Junyang, et al.
Publicado: (2014)

Azvudine (FNC): a promising clinical candidate for COVID-19 treatment
por: Yu, Bin, et al.
Publicado: (2020)

Targeting PCSK9: a promising adjuvant strategy in cancer immunotherapy
por: Almeida, Catarina R., et al.
Publicado: (2021)

Base editing: a promising tool to rescue spinal muscular atrophy
por: Bhatia, Priyanka, et al.
Publicado: (2023)

Investigation of Polyamine Metabolism and Homeostasis in Pancreatic Cancers
por: Massaro, Chelsea, et al.
Publicado: (2017)

CRISPR-mediated RNA base editing: a promising strategy to rescue deafness
por: Liu, Wenyi, et al.
Publicado: (2023)

FcγRIIb blockage: a promising immunotherapy target for severe COVID-19
por: He, Xuemei, et al.
Publicado: (2021)

High-throughput base editing: a promising technology for precision medicine and drug discovery
por: Sachinidis, Agapios
Publicado: (2021)

Dietary reprogram of macrophages for cell competition: a promising strategy for malignant cancer control
por: Chen, Jian, et al.
Publicado: (2023)

A metabolic profile of polyamines in parkinson disease: A promising biomarker
por: Saiki, Shinji, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_fo6eu693p1q89e95n4j792rl89